![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Drug-Drug Interactions of the Direct Acting Antiviral Regimen of ABT-450/r, Ombitasvir and Dasabuvir with Emtricitabine + Tenofovir, Raltegravir, Rilpivirine and Efavirenz
|
|
|
Reported by Jules Levin
ICAAC 2014 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 5-9, 2014, Washington, DC
A. Khatri, T. Wang, H. Wang, T. Podsadecki, R. Trinh, W. Awni, S. Dutta, R. Menon
AbbVie Inc., Research and Development, North Chicago, Illinois 60064, United States
![HCV1.gif](../images/090814/090814-16/HCV1.gif)
![HCV2.gif](../images/090814/090814-16/HCV2.gif)
![HCV3.gif](../images/090814/090814-16/HCV3.gif)
![HCV4.gif](../images/090814/090814-16/HCV4.gif)
![HCV5.gif](../images/090814/090814-16/HCV5.gif)
![HCV6.gif](../images/090814/090814-16/HCV6.gif)
![HCV7.gif](../images/090814/090814-16/HCV7.gif)
![HCV8.gif](../images/090814/090814-16/HCV8.gif)
![HCV9.gif](../images/090814/090814-16/HCV9.gif)
![HCV10.gif](../images/090814/090814-16/HCV10.gif)
![HCV11.gif](../images/090814/090814-16/HCV11.gif)
![HCV12.gif](../images/090814/090814-16/HCV12.gif)
![HCV13.gif](../images/090814/090814-16/HCV13.gif)
![HCV14.gif](../images/090814/090814-16/HCV14.gif)
![HCV15.gif](../images/090814/090814-16/HCV15.gif)
![HCV16.gif](../images/090814/090814-16/HCV16.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|